Inflammatory response of tumor-activated hepatic sinusoidal endothelium as a target for the screening of metastasis chemopreventive drugs.
Mendoza
Lorea
L
PharmaKine Ltd., Zamudio Technology Park, Bizkaia, Spain.
Vidal-Vanaclocha
Fernando
F
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002448:Cell Adhesion; D016207:Cytokines / Q000378:metabolism; D004354:Drug Screening Assays, Antitumor; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D007249:Inflammation; D008099:Liver / Q000098:blood supply*; D008114:Liver Neoplasms, Experimental / Q000517:prevention & control / Q000556:secondary*; D008297:Male; D051379:Mice; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009368:Neoplasm Transplantation; D014407:Tumor Cells, Cultured / Q000637:transplantation; D019010:Vascular Cell Adhesion Molecule-1 / Q000096:biosynthesis
D000970:Antineoplastic Agents; D016207:Cytokines; D019010:Vascular Cell Adhesion Molecule-1